The aim of our work was to decipher the relation between the molecular subtype classification as defined by a combination of ER and HER2 status and the probability of a positive non-sentinel node biopsy of breast cancer patients with metastatic sentinel lymph node. This evidence concerns the gene ESR1 and breast carcinoma.